E
EGBOT
Guest
Atopix raises additional development capital to investigate OC459 for treatment of asthma
Source: Atopix raises additional development capital to investigate OC459 for treatment of asthma
HTML:
Atopix Therapeutics Limited, a UK biopharmaceutical company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announced that it has raised additional development capital to advance its lead product OC459 for the treatment of asthma.
Source: Atopix raises additional development capital to investigate OC459 for treatment of asthma